PAPER Cirillo G, Bianco MR, Colangelo AM, Cavaliere C, Daniele de, Zaccaro L, Alberghina L, Papa M
SEARCH RESULTS
330988 RESULTS
PAPER Murphy KJ, Miller AM, Thelma R, Cowley F, Cox FF, Lynch MA
The age- and amyloid-β-related increases in Nogo B contribute to microglial activation.
Neurochem Int. 2011 Feb;58(2):161-8. PubMed: 21111015PAPER McDonald CL, Bandtlow C, Reindl M
Targeting the Nogo receptor complex in diseases of the central nervous system.
Curr Med Chem. 2011;18(2):234-44. PubMed: 21110803PAPER Park MH, Min JY, Kwon DY, Lee SH, Na HR, Cho ST, Na DL
Vascular risk factors and the effect of white matter lesions on extrapyramidal signs in Alzheimer's disease.
Int Psychogeriatr. 2010 Nov 29;:1-8. PubMed: 21110907PAPER Mittal G, Carswell H, Brett R, Currie S, Kumar MN
Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology.
J Control Release. 2011 Mar 10;150(2):220-8. PubMed: 21111014PAPER Ghalkhani M, Fernandes IP, Oliveira SC, Shahrokhian S, Oliveira-Brett AM
Anodic behavior of clioquinol at a glassy carbon electrode.
Bioelectrochemistry. 2011 Feb;80(2):175-81. PubMed: 21111689PAPER Yi KD, Perez E, Yang S, Liu R, Covey DF, Simpkins JW
The assessment of non-feminizing estrogens for use in neuroprotection.
Brain Res. 2011 Mar 16;1379:61-70. PubMed: 21111714PAPER Vaidya S, Velázquez-Delgado EM, Abbruzzese G, Hardy JA
Substrate-induced conformational changes occur in all cleaved forms of caspase-6.
J Mol Biol. 2011 Feb 11;406(1):75-91. PubMed: 21111746PAPER Yamagishi S
Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.
Exp Gerontol. 2011 Apr;46(4):217-24. PubMed: 21111800PAPER Kroksveen AC, Opsahl JA, Aye TT, Ulvik RJ, Berven FS
Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
J Proteomics. 2011 Apr 1;74(4):371-88. PubMed: 21111852PAPER Ko CY, Chang LH, Lee YC, Sterneck E, Cheng CP, Chen SH, Huang AM, Tseng JT, Wang JM
CCAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells.
Neurobiol Aging. 2012 Feb;33(2):422.e11-25. PubMed: 21112127PAPER Nithianantharajah J, Hannan AJ
Mechanisms mediating brain and cognitive reserve: experience-dependent neuroprotection and functional compensation in animal models of neurodegenerative diseases.
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):331-9. PubMed: 21112312PAPER Kurata T, Miyazaki K, Kozuki M, Panin VL, Morimoto N, Ohta Y, Nagai M, Ikeda Y, Matsuura T, Abe K
Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice.
Brain Res. 2011 Jan 31;1371:161-70. PubMed: 21112317PAPER Humpel C
Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?
Exp Gerontol. 2011 Apr;46(4):225-32. PubMed: 21112383PAPER Barr TL, Alexander S, Conley Y
Gene expression profiling for discovery of novel targets in human traumatic brain injury.
Biol Res Nurs. 2011 Apr;13(2):140-53. PubMed: 21112922Current Filters
No filters selected